Surgalign Holdings, Inc. Schedules First Quarter 2022 Earnings Release for May 10, 2022
April 26 2022 - 4:30PM
Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical
technology company focused on elevating the standard of care
through the evolution of digital surgery, today announced it plans
to release financial results from the first quarter 2022 after the
close of trading on May 10th, 2022.
Surgalign will host a conference call and audio
webcast at 4:30 p.m. ET the same day. The conference call can be
accessed by dialing (866) 604-1616 (U.S.) or (201) 689-8043
(International). The webcast can be accessed through the investor
section of Surgalign’s website at surgalign.com/investors/. A
replay of the conference call will be available on Surgalign’s
website for one month following the call.
About Surgalign Holdings,
Inc.
Surgalign Holdings, Inc. is a global medical
technology company committed to the promise of digital health to
drive transformation across the surgical landscape. Uniquely
aligned and resourced to advance the standard of care, the company
is building technologies physicians and other health providers will
look to for what is truly possible for their patients. Surgalign is
focused on developing solutions that predictably deliver superior
clinical and economic outcomes. Surgalign markets products
throughout the United States and in more than 50 countries
worldwide through an expanding network of top independent
distributors. Surgalign is headquartered in Deerfield, IL, with
commercial, innovation and design centers in San Diego, CA, Warsaw
and Poznan, Poland and Wurmlingen, Germany. Learn more at
www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are based on
management’s current expectations, estimates and projections about
our industry, our management's beliefs and certain assumptions made
by our management. Words such as "anticipates," "expects,"
"intends," "plans," "believes," "seeks," "estimates," variations of
such words and similar expressions are intended to identify such
forward-looking statements. These statements are not guarantees of
future performance and are subject to risks and uncertainties,
including the risks described in public filings with the U.S.
Securities and Exchange Commission (SEC). Our actual results may
differ materially from the anticipated results reflected in these
forward-looking statements. Copies of the company's SEC filings may
be obtained by contacting the company or the SEC or by visiting
Surgalign's website at www.surgalign.com or the SEC's website
at www.sec.gov.
Investor and Media Contact: Mike Vallie
IR@surgalign.com +1 443 213 0499
Surgalign Contact:Kristine
Simmonsksimmons@surgalign.com +1 619 206 4648
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Apr 2023 to Apr 2024